Cargando…

Dysregulated CD4(+) T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr(−/−) mice

OBJECTIVE: Accelerated atherosclerosis is a major source of morbidity in systemic lupus erythematosus (SLE). However, the cause of SLE-accelerated atherosclerosis remains unclear. METHODS: CD4(+) T cells from C57/Bl/6 (B6) or SLE-susceptible B6.Sle1.2.3 (B6.SLE) mice were transferred into LDLr(−/−),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilhelm, Ashley J, Rhoads, Jillian P, Wade, Nekeithia S, Major, Amy S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Basic and Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083014/ https://www.ncbi.nlm.nih.gov/pubmed/24395554 http://dx.doi.org/10.1136/annrheumdis-2013-203759

Ejemplares similares

T Cells in Atherosclerosis in Ldlr−/− and Apoe−/− Mice
por: Getz, Godfrey S., et al.
Publicado: (2018)

PAR4 Inhibition Reduces Coronary Artery Atherosclerosis and Myocardial Fibrosis in SR-B1/LDLR Double Knockout Mice
por: Lee, Samuel K., et al.
Publicado: (2023)

The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-γ production in T cells from patients with SLE
por: Hagberg, Niklas, et al.
Publicado: (2018)

Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice
por: Park, Kyung-Yeon, et al.
Publicado: (2016)

Poloxamer 407 Induces Hypertriglyceridemia but Decreases Atherosclerosis in Ldlr(−/−) Mice
por: Peng, Xueying, et al.
Publicado: (2022)

Atherosclerosis Susceptibility in Mice Is Independent of the V1 Immunoglobulin Heavy Chain Gene
por: Centa, Monica, et al.
Publicado: (2016)

B cell OX40L supports T follicular helper cell development and contributes to SLE pathogenesis
por: Cortini, Andrea, et al.
Publicado: (2017)

Epigenetic dysregulation in meningiomas
por: Wedemeyer, Michelle A, et al.
Publicado: (2022)

Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice
por: Babaev, Vladimir R., et al.
Publicado: (2014)

Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr(−/−) mice
por: Rajamoorthi, Ananthi, et al.
Publicado: (2018)

Tanshinone IIA alleviates atherosclerosis in LDLR(−/−) mice by regulating efferocytosis of macrophages
por: Wang, Jiarou, et al.
Publicado: (2023)

HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE
por: Caza, Tiffany N, et al.
Publicado: (2014)

3293 Region Specific Dysregulation of Dopaminergic Signaling in Mice Displaying Excessive Over-Grooming
por: Foster, Daniel, et al.
Publicado: (2019)

Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice
por: Bisgaard, Line S., et al.
Publicado: (2016)

Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr(−/−) mice
por: Tao, Huan, et al.
Publicado: (2020)

Dysregulated bioenergetics: a key regulator of joint inflammation
por: Biniecka, M, et al.
Publicado: (2016)

CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO mice
por: Riopel, Matthew, et al.
Publicado: (2018)

Increased Inflammation in Atherosclerotic Lesions of Diabetic Akita-LDLr (−/−) Mice Compared to Nondiabetic LDLr (−/−) Mice
por: Engelbertsen, Daniel, et al.
Publicado: (2012)

Osteopontin regulates human glioma cell invasiveness and tumor growth in mice
por: Jan, Hsun-Jin, et al.
Publicado: (2010)

Effects Of treadmill training on hindlimb muscles of spinal cord–injured mice
por: Battistuzzo, Camila R., et al.
Publicado: (2016)

Pharmacokinetic properties of the temozolomide perillyl alcohol conjugate (NEO212) in mice
por: Cho, Hee-Yeon, et al.
Publicado: (2020)

A novel mouse model that develops spontaneous arthritis and is predisposed towards atherosclerosis
por: Rose, Shawn, et al.
Publicado: (2013)

The heart-gut axis: new target for atherosclerosis and congestive heart failure therapy
por: Forkosh, Esther, et al.
Publicado: (2019)

Loss of Rictor in Monocyte/Macrophages Suppresses Their Proliferation and Viability Reducing Atherosclerosis in LDLR Null Mice
por: Babaev, Vladimir R., et al.
Publicado: (2018)

The Cordyceps militaris-Derived Polysaccharide CM1 Alleviates Atherosclerosis in LDLR((-/-)) Mice by Improving Hyperlipidemia
por: Yin, Fan, et al.
Publicado: (2021)

Increasing Atherosclerosis in Streptozotocin-Induced Diabetes into Four Groups of Mice
por: Ritarwan, Kiking, et al.
Publicado: (2018)

Impact of Gut Microbiota and Diet on the Development of Atherosclerosis in Apoe(−/−) Mice
por: Lindskog Jonsson, Annika, et al.
Publicado: (2018)

Anesthesia triggers drug delivery to experimental glioma in mice by hijacking caveolar transport
por: Spieth, Lena, et al.
Publicado: (2021)

Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
por: de Groot, John F., et al.
Publicado: (2010)

Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity
por: Banerjee, Poulabi, et al.
Publicado: (2019)

Dysregulated miRNome of plasmacytoid dendritic cells from patients with Sjögren’s syndrome is associated with processes at the centre of their function
por: Hillen, Maarten R, et al.
Publicado: (2019)

The Sirt1 activator SRT3025 provides atheroprotection in Apoe(−/−) mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression
por: Miranda, Melroy X., et al.
Publicado: (2015)

Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E(−/−) Mice
por: Rinne, Petteri, et al.
Publicado: (2018)

Different Susceptibilities between Apoe- and Ldlr-Deficient Mice to Inflammation-Associated Colorectal Carcinogenesis
por: Tanaka, Takuji, et al.
Publicado: (2016)

The Effects of Selective Hematopoietic Expression of Human IL-37 on Systemic Inflammation and Atherosclerosis in LDLr-Deficient Mice
por: Hoeke, Geerte, et al.
Publicado: (2017)

Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr(−/−) Mice
por: Subramanian, Savitha, et al.
Publicado: (2018)

The secretome of liver X receptor agonist‐treated early outgrowth cells decreases atherosclerosis in Ldlr−/− mice
por: Rasheed, Adil, et al.
Publicado: (2020)

Assessment of intensive care unit‐acquired weakness in young and old mice: An E. coli septic peritonitis model
por: Witteveen, Esther, et al.
Publicado: (2015)

Overexpression of HGF/MET axis along with p53 inhibition induces de novo glioma formation in mice
por: Qin, Yuan, et al.
Publicado: (2020)

Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor α (WSX-1)
por: Sugiyama, N, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_f8688t8kr8pcnibg1tclqs4kd4